Oppenheimer Reiterates Outperform Rating on Amgen (AMGN), remains well-positioned across various Horizon (HZNP) scenarios
Go back to Oppenheimer Reiterates Outperform Rating on Amgen (AMGN), remains well-positioned across various Horizon (HZNP) scenarios| Amgen Inc (NASDAQ: AMGN) | Delayed: 415.21 -2.63 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $417.84 | 52 Week High | $176.85 | |||
| Open | $413.76 | 52 Week Low | $133.64 | |||
| Day High | $416.03 | P/E | 62.53 | |||
| Day Low | $410.50 | EPS | $6.64 | |||
| Volume | 2,036,286 | |||||
| HORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.30 | 52 Week High | $23.44 | |||
| Open | $19.84 | 52 Week Low | $13.06 | |||
| Day High | $116.30 | P/E | N/A | |||
| Day Low | $116.30 | EPS | $-0.96 | |||
| Volume | 283,408 | |||||
